| Name | Title | Contact Details |
|---|
Gourmet-To-Go is a Maryland Heights, MO-based company in the Business Services sector.
Aegon Asset Management is a global, active investment manager. We use our investment management expertise to help people achieve a lifetime of financial security, with a focus on excellence, trust and partnership.
Vo Data Solutions Inc is a De Soto, MO-based company in the Business Services sector.
Grüneberg and Myers PLLC was founded in 2017. Less than 3 years later the firm was listed in IAM Patent 1000 by Intellectual Asset Management as one of the worlds leading IP firms. IAM notes: "A model of flexibility, speed, cost effectiveness and quality, forward-looking Tysons, Virginia patent boutique Grüneberg and Myers has recorded striking growth of late. With prosecution the bedrock of its practice, the ensemble has been structuring robust protection for a host of global companies across multiple industries. It is not just a filing shop, though; strategic value is packed into every direction it provides on matters such as product clearance. Taking charge is Kirsten A Grüneberg, a chemical, biotech and pharmaceutical expert who provides "quick, straightforward but thorough advice" and "achieves the maximum scope of protection in the most efficient way". Having started from scratch just two years ago, her team is up to an impressive total of 18 people; Grüneberg has hired astutely, too, selecting individuals with in-house experience, international expertise and technical fluency." The firm is 100% women and ethnic minority owned.
Metsera is a clinical-stage biopharmaceutical company based in New York City, dedicated to developing innovative treatments for obesity and metabolic diseases. Founded in 2022 by Population Health Partners and ARCH Venture Partners, the company has raised $290 million from prominent healthcare investors to support its research and development initiatives. Metsera is advancing a diverse portfolio of oral and injectable therapies, including incretin, non-incretin, and combination treatments. These therapies target various aspects of weight loss and are developed from a proprietary library of over 20,000 gut hormone peptides and peptide/antibody conjugates. A notable partnership with Amneal Pharmaceuticals focuses on the development and supply of its investigational weight loss therapy, MET-097.